Drugs Made in America Acquisition (DMAAU) Competitors $10.19 -0.02 (-0.20%) As of 05/1/2025 03:55 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock DMAAU vs. ASPCU, AGBAW, AGNCP, AGNCO, AGNCN, AGNCM, AGNCL, ANSCW, ANSCU, and AITRUShould you be buying Drugs Made in America Acquisition stock or one of its competitors? The main competitors of Drugs Made in America Acquisition include A SPAC III Acquisition (ASPCU), AGBA Group (AGBAW), AGNC Investment (AGNCP), AGNC Investment (AGNCO), AGNC Investment (AGNCN), AGNC Investment (AGNCM), AGNC Investment (AGNCL), Agriculture & Natural Solutions Acquisition (ANSCW), Agriculture & Natural Solutions Acquisition (ANSCU), and AI Transportation Acquisition (AITRU). These companies are all part of the "trading" industry. Drugs Made in America Acquisition vs. A SPAC III Acquisition AGBA Group AGNC Investment AGNC Investment AGNC Investment AGNC Investment AGNC Investment Agriculture & Natural Solutions Acquisition Agriculture & Natural Solutions Acquisition AI Transportation Acquisition A SPAC III Acquisition (NASDAQ:ASPCU) and Drugs Made in America Acquisition (NASDAQ:DMAAU) are both finance companies, but which is the better investment? We will contrast the two companies based on the strength of their community ranking, profitability, institutional ownership, analyst recommendations, risk, valuation, earnings, dividends and media sentiment. Does the media favor ASPCU or DMAAU? In the previous week, A SPAC III Acquisition had 2 more articles in the media than Drugs Made in America Acquisition. MarketBeat recorded 3 mentions for A SPAC III Acquisition and 1 mentions for Drugs Made in America Acquisition. Drugs Made in America Acquisition's average media sentiment score of 1.87 beat A SPAC III Acquisition's score of 0.29 indicating that Drugs Made in America Acquisition is being referred to more favorably in the news media. Company Overall Sentiment A SPAC III Acquisition Neutral Drugs Made in America Acquisition Very Positive Is ASPCU or DMAAU more profitable? Company Net Margins Return on Equity Return on Assets A SPAC III AcquisitionN/A N/A N/A Drugs Made in America Acquisition N/A N/A N/A Which has higher earnings and valuation, ASPCU or DMAAU? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioA SPAC III AcquisitionN/AN/AN/AN/AN/ADrugs Made in America AcquisitionN/AN/AN/AN/AN/A Does the MarketBeat Community believe in ASPCU or DMAAU? A SPAC III Acquisition and Drugs Made in America Acquisition both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformA SPAC III AcquisitionN/AN/ADrugs Made in America AcquisitionN/AN/A SummaryA SPAC III Acquisition and Drugs Made in America Acquisition tied by winning 1 of the 2 factors compared between the two stocks. Get Drugs Made in America Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for DMAAU and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DMAAU vs. The Competition Export to ExcelMetricDrugs Made in America AcquisitionInvestment Offices IndustryFinance SectorNASDAQ ExchangeMarket CapN/A$187.75M$11.11B$7.92BDividend YieldN/AN/A5.77%4.22%P/E RatioN/AN/A22.1018.54Price / SalesN/AN/A26.31103.35Price / CashN/AN/A17.6034.62Price / BookN/AN/A2.674.25Net IncomeN/AN/A$1.03B$248.18M7 Day Performance0.30%-0.76%0.77%1.25%1 Month Performance0.69%0.49%-0.17%3.76%1 Year PerformanceN/A29.84%538.56%5.28% Drugs Made in America Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DMAAUDrugs Made in America AcquisitionN/A$10.19-0.2%N/AN/A$0.00N/A0.002Positive NewsASPCUA SPAC III AcquisitionN/A$10.23+0.2%N/AN/A$0.00N/A0.00N/ALockup ExpirationPositive NewsAGBAWAGBA GroupN/A$0.10-5.4%N/A-58.2%$0.00$38.55M0.00152Gap DownAGNCPAGNC InvestmentN/A$24.66+0.1%N/A+5.6%$0.00$584M0.0050Short Interest ↓AGNCOAGNC InvestmentN/A$24.98-0.1%N/A+1.5%$0.00$584M0.0050Positive NewsAGNCNAGNC InvestmentN/A$25.40-0.2%N/A-0.1%$0.00$584M0.0050Short Interest ↓AGNCMAGNC InvestmentN/A$24.43-0.4%N/A-0.7%$0.00$584M0.0050AGNCLAGNC InvestmentN/A$25.10+2.1%N/A+7.5%$0.00$584M0.0050Short Interest ↓News CoverageANSCWAgriculture & Natural Solutions AcquisitionN/A$0.18-0.1%N/A-28.6%$0.00N/A0.00N/APositive NewsGap DownANSCUAgriculture & Natural Solutions AcquisitionN/A$10.790.0%N/A+4.2%$0.00N/A0.00N/APositive NewsAITRUAI Transportation AcquisitionN/A$11.24flatN/AN/A$0.00N/A0.00N/APositive News Related Companies and Tools Related Companies A SPAC III Acquisition Competitors AGBA Group Competitors AGNC Investment Competitors AGNC Investment Competitors AGNC Investment Competitors AGNC Investment Competitors AGNC Investment Competitors Agriculture & Natural Solutions Acquisition Competitors Agriculture & Natural Solutions Acquisition Competitors AI Transportation Acquisition Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:DMAAU) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMassive dollar overhaul underway in D.C.?Trump's plan to save the U.S. Dollar The U.S. Dollar is crashing, and our reserve currency status is now in...Stansberry Research | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Drugs Made in America Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Drugs Made in America Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.